Enhanced immigration enforcement in the USA and the transnational continuity of HIV care for Latin American immigrants in deportation proceedings

Kathleen R Page, Suzanne Grieb, Karen Nieves-Lugo, Thespina Yamanis, Holly Taylor, Omar Martinez, Yoshiaki Yamasaki, Rupali J Limaye, Wendy Davis, Christopher Beyrer, María Cecilia Zea

Research output: Contribution to journalArticle

Abstract

In our work as clinicians, researchers, and immigrant rights advocates, we have noted increased anxiety about the possibility of deportation and disruptions in care among immigrants with HIV. Before the 2016 US elections, patients rarely asked about HIV treatment in their home countries. However, since the increase in anti-immigrant rhetoric and arrests by US Immigration and Customs Enforcement, patients have voiced concerns about the availability of HIV treatment in their home countries much more frequently. Although antiretroviral therapy is available throughout Latin America, access depends on economic, social, and political circumstances. Maintaining uninterrupted continuity of care among immigrants held in detention or deported to their home countries is challenging. In this Viewpoint, we identify periods of particular vulnerability for immigrants during deportation proceedings, from initial detention to deposition in their country of origin. We discuss the effect of enhanced immigration enforcement on the health and wellbeing of HIV-infected immigrants, and on public health. Finally, we also discuss recommendations for clinicians, immigration authorities, and public health institutions in the USA and in receiving countries.

Original languageEnglish (US)
JournalThe Lancet HIV
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Continuity of Patient Care
Emigration and Immigration
HIV
Public Health
Latin America
Therapeutics
Anxiety
Economics
Research Personnel
Health

ASJC Scopus subject areas

  • Epidemiology
  • Immunology
  • Infectious Diseases
  • Virology

Cite this

Enhanced immigration enforcement in the USA and the transnational continuity of HIV care for Latin American immigrants in deportation proceedings. / Page, Kathleen R; Grieb, Suzanne; Nieves-Lugo, Karen; Yamanis, Thespina; Taylor, Holly; Martinez, Omar; Yamasaki, Yoshiaki; Limaye, Rupali J; Davis, Wendy; Beyrer, Christopher; Zea, María Cecilia.

In: The Lancet HIV, 01.01.2018.

Research output: Contribution to journalArticle

@article{503642daeca947d38556111bb18474b7,
title = "Enhanced immigration enforcement in the USA and the transnational continuity of HIV care for Latin American immigrants in deportation proceedings",
abstract = "In our work as clinicians, researchers, and immigrant rights advocates, we have noted increased anxiety about the possibility of deportation and disruptions in care among immigrants with HIV. Before the 2016 US elections, patients rarely asked about HIV treatment in their home countries. However, since the increase in anti-immigrant rhetoric and arrests by US Immigration and Customs Enforcement, patients have voiced concerns about the availability of HIV treatment in their home countries much more frequently. Although antiretroviral therapy is available throughout Latin America, access depends on economic, social, and political circumstances. Maintaining uninterrupted continuity of care among immigrants held in detention or deported to their home countries is challenging. In this Viewpoint, we identify periods of particular vulnerability for immigrants during deportation proceedings, from initial detention to deposition in their country of origin. We discuss the effect of enhanced immigration enforcement on the health and wellbeing of HIV-infected immigrants, and on public health. Finally, we also discuss recommendations for clinicians, immigration authorities, and public health institutions in the USA and in receiving countries.",
author = "Page, {Kathleen R} and Suzanne Grieb and Karen Nieves-Lugo and Thespina Yamanis and Holly Taylor and Omar Martinez and Yoshiaki Yamasaki and Limaye, {Rupali J} and Wendy Davis and Christopher Beyrer and Zea, {Mar{\'i}a Cecilia}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/S2352-3018(18)30074-2",
language = "English (US)",
journal = "The Lancet HIV",
issn = "2352-3018",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Enhanced immigration enforcement in the USA and the transnational continuity of HIV care for Latin American immigrants in deportation proceedings

AU - Page, Kathleen R

AU - Grieb, Suzanne

AU - Nieves-Lugo, Karen

AU - Yamanis, Thespina

AU - Taylor, Holly

AU - Martinez, Omar

AU - Yamasaki, Yoshiaki

AU - Limaye, Rupali J

AU - Davis, Wendy

AU - Beyrer, Christopher

AU - Zea, María Cecilia

PY - 2018/1/1

Y1 - 2018/1/1

N2 - In our work as clinicians, researchers, and immigrant rights advocates, we have noted increased anxiety about the possibility of deportation and disruptions in care among immigrants with HIV. Before the 2016 US elections, patients rarely asked about HIV treatment in their home countries. However, since the increase in anti-immigrant rhetoric and arrests by US Immigration and Customs Enforcement, patients have voiced concerns about the availability of HIV treatment in their home countries much more frequently. Although antiretroviral therapy is available throughout Latin America, access depends on economic, social, and political circumstances. Maintaining uninterrupted continuity of care among immigrants held in detention or deported to their home countries is challenging. In this Viewpoint, we identify periods of particular vulnerability for immigrants during deportation proceedings, from initial detention to deposition in their country of origin. We discuss the effect of enhanced immigration enforcement on the health and wellbeing of HIV-infected immigrants, and on public health. Finally, we also discuss recommendations for clinicians, immigration authorities, and public health institutions in the USA and in receiving countries.

AB - In our work as clinicians, researchers, and immigrant rights advocates, we have noted increased anxiety about the possibility of deportation and disruptions in care among immigrants with HIV. Before the 2016 US elections, patients rarely asked about HIV treatment in their home countries. However, since the increase in anti-immigrant rhetoric and arrests by US Immigration and Customs Enforcement, patients have voiced concerns about the availability of HIV treatment in their home countries much more frequently. Although antiretroviral therapy is available throughout Latin America, access depends on economic, social, and political circumstances. Maintaining uninterrupted continuity of care among immigrants held in detention or deported to their home countries is challenging. In this Viewpoint, we identify periods of particular vulnerability for immigrants during deportation proceedings, from initial detention to deposition in their country of origin. We discuss the effect of enhanced immigration enforcement on the health and wellbeing of HIV-infected immigrants, and on public health. Finally, we also discuss recommendations for clinicians, immigration authorities, and public health institutions in the USA and in receiving countries.

UR - http://www.scopus.com/inward/record.url?scp=85049483816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049483816&partnerID=8YFLogxK

U2 - 10.1016/S2352-3018(18)30074-2

DO - 10.1016/S2352-3018(18)30074-2

M3 - Article

C2 - 29997050

AN - SCOPUS:85049483816

JO - The Lancet HIV

JF - The Lancet HIV

SN - 2352-3018

ER -